Patents Assigned to MEDICINE PARK CO., LTD.
  • Patent number: 11801260
    Abstract: Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.
    Type: Grant
    Filed: February 11, 2022
    Date of Patent: October 31, 2023
    Assignee: MEDICINE PARK CO., LTD
    Inventors: Yoo Sin Park, Il Hoon Lee
  • Patent number: 11278565
    Abstract: Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: March 22, 2022
    Assignee: MEDICINE PARK CO., LTD.
    Inventors: Yoo Sin Park, Il Hoon Lee